+

WO1999033958A2 - Desaturase - Google Patents

Desaturase Download PDF

Info

Publication number
WO1999033958A2
WO1999033958A2 PCT/GB1998/003895 GB9803895W WO9933958A2 WO 1999033958 A2 WO1999033958 A2 WO 1999033958A2 GB 9803895 W GB9803895 W GB 9803895W WO 9933958 A2 WO9933958 A2 WO 9933958A2
Authority
WO
WIPO (PCT)
Prior art keywords
dna sequence
polypeptide
fatty acid
sequence
organism
Prior art date
Application number
PCT/GB1998/003895
Other languages
English (en)
Other versions
WO1999033958A3 (fr
Inventor
Johnathan A. Napier
Louise Michaelson
Keith Stobart
Original Assignee
University Of Bristol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9727256.1A external-priority patent/GB9727256D0/en
Priority claimed from GBGB9814034.6A external-priority patent/GB9814034D0/en
Priority to HU0101153A priority Critical patent/HUP0101153A3/hu
Priority to KR1020007007019A priority patent/KR20010033517A/ko
Priority to PL98344868A priority patent/PL344868A1/xx
Priority to CA002315297A priority patent/CA2315297A1/fr
Application filed by University Of Bristol filed Critical University Of Bristol
Priority to BR9814434-0A priority patent/BR9814434A/pt
Priority to EP98962620A priority patent/EP1042485A2/fr
Priority to EEP200000372A priority patent/EE200000372A/xx
Priority to AU17748/99A priority patent/AU1774899A/en
Priority to JP2000526616A priority patent/JP2002508932A/ja
Publication of WO1999033958A2 publication Critical patent/WO1999033958A2/fr
Publication of WO1999033958A3 publication Critical patent/WO1999033958A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083—Miscellaneous (1.14.99)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Definitions

  • This invention relates to DNA sequences encoding ⁇ 5-fatty acid desaturases, the encoded ⁇ 5-fatty acid desaturases, and applications for the ⁇ 5-fatty acid desaturases.
  • Polyunsaturated fatty acids are important neutraceutically due to their specific health
  • Polyunsaturated fatty acids are the precursors for two major classes of metabolites:
  • prostanoids which include prostaglandins and thromboxanes
  • leukotrienes which include leukotrienes
  • ⁇ 5-fatty acid desaturase catalyses the conversion of dihomogamma linolenic acid (DHL) to
  • Arachidonic acid has a 20 carbon chain with 4 double bonds and is of great importance in
  • Prostaglandins are modulators of hormone action and the potential effects of prostaglandins include the stimulation of inflammation
  • polyunsaturated fatty acids from these sources include solvent extraction, winterization,
  • GLA ⁇ -linolenate
  • DHGLA dihomo- ⁇ (-linolenate
  • AA eicosapentaenoate
  • DHA docosahezaenoate
  • biosynthetic capacity of lower organisms e.g. algae, bacteria, fungi (including
  • Polyunsaturated fatty acid metabolism is of greatest importance in human metabolism.
  • the inventors have surprisingly isolated and characterised a DNA sequence from the
  • the DNA sequences of this invention may enable the cloning
  • Plant and fungal desaturases are mainly integral membrane polypeptides which makes them
  • a first aspect of the invention provides an isolated animal ⁇ 5-fatty acid desaturase and functional portions thereof.
  • a second aspect of the invention provides an isolated C. elegans ⁇ 5-fatty acid desaturase.
  • a third aspect of the invention provides a DNA sequence according to a first or second aspect of the invention comprises at least a portion of the sequence shown in SEQ.2 and equivalents to that sequence, or to portions of that sequence, which encode a functional ⁇ 5-fatty acid desaturase by virtue of the degeneracy of the genetic code.
  • the DNA sequence is derived from a Caenorhabditis elegans DNA sequence.
  • the gene encoding the ⁇ 5-fatty acid desaturase encoded by the cloned gene is 1341 bp long.
  • the protein is 447 amino acids long with an estimated molecular weight of 57 kDa.
  • the DNA sequence encodes a functional ⁇ 5-fatty acid desaturase and comprises at least a portion of the sequence shown in SEQ.l and equivalents to that sequence, or to portions of that sequence, which encode a functional ⁇ 5-fatty acid desaturase by virtue of the degeneracy of the genetic code.
  • the DNA sequence is derived from a Mortierella alpina DNA sequence.
  • the gene encoding the ⁇ 5-fatty acid desaturase encoded by the cloned gene is 1338 bp long.
  • the protein is 446 amino acids long with an estimated molecular weight of 57 kDa.
  • a DNA sequence according to a third aspect of the invention is functional in a mammal.
  • the DNA sequence is expressed in a mammal.
  • the DNA sequence is expressed in a human.
  • the DNA sequence is obtained by modification of a functional natural gene encoding a ⁇ -5 fatty acid desaturase.
  • the modification includes modification by chemical, physical, or biological means without removing a catalytic activity of the enzyme which it encodes.
  • the modification improves a catalytic activity of the enzyme which it encodes.
  • the biological modification includes recombinant DNA methods and forced evolution techniques.
  • the forced evolution technique is DNA shuffling.
  • a fourth aspect of the invention provides a polypeptide encoded by a DNA sequence according to a third aspect of the invention.
  • polypeptide has the sequence shown in SEQ.3 or functional equivalents to that sequence or portions of that sequence.
  • polypeptide has the sequence shown in SEQ.4 or functional equivalents to that sequence or portions of that sequence.
  • the polypeptide catalyses the conversion of dihomogamma linolenic acid to arachidonic acid.
  • the polypeptide has been modified without removing the catalytic activity of the encoded polypeptide.
  • the polypeptide has been modified in such a way as to introduce a specific level of saturation of a substrate at a specific location within the molecular structure of the substrate.
  • a fifth aspect of the invention provides a vector containing a DNA sequence of any portion of a DNA sequence according to a third aspect of the invention..
  • a sixth aspect of the invention provides a method of producing polyunsaturated fatty acids comprising contacting a substrate with a ⁇ 5-fatty acid desaturase according to a first or second aspect of the invention, or a polypeptide according to a fourth aspect of the invention.
  • a seventh aspect of the invention provides a method of converting dihomogamma linoleic acid to arachidonic acid wherein the conversion is catalysed by a ⁇ 5-fatty acid desaturase according to a first or second aspect of the invention, or a polypeptide according to a fourth aspect of the invention.
  • An eighth aspect of the invention provides an organism engineered to produce high levels of a polypeptide according to a fourth aspect of the invention.
  • a ninth aspect of the invention provides an organism engineered to produce high levels of a product of a reaction catalysed by a ⁇ 5-fatty acid desaturase according to a first or second aspect of the invention, or by a polypeptide according to a fourth aspect of the invention.
  • the organism has been engineered to carry out the method according to a sixth or seventh aspect of the invention.
  • the organism is a microorganism.
  • the microorganism is selected from algae, bacteria and fungi.
  • the fungi includes phycomycetes.
  • the microorganism is a yeast.
  • the organism is a plant.
  • the plant is selected from oil seed plants.
  • the oil seed plants are selected from oil seed rape, sunflower, cereals including maize, tobacco, legumes including peanut and soybean, safflower, oil palm, coconut and other palms, cotton, sesame, mustard, linseed, castor, borage and evening primrose.
  • a tenth aspect of the invention provides a seed or other reproductive material derived from an organism according to a ninth aspect of the invention.
  • the organism is a mammal.
  • An eleventh aspect of the invention provides an isolated multienzyme pathway wherein the pathway includes a ⁇ 5-fatty acid desaturase according to a first or second aspect of the invention.
  • a twelfth aspect of the invention provides a compound produced by a conversion of a substrate, wherein said conversion is catalysed by a ⁇ 5-fatty acid desaturase according to a first or second aspect of the invention.
  • a thirteenth aspect of the invention provides an intermediate compound produced by the reaction catalysed by a ⁇ 5-fatty acid desaturase according to a first or second aspect of the invention.
  • a fourteenth aspect of the invention provides a foodstuff or dietary supplement containing a polyunsaturated fatty acid produced by a method according to a sixth aspect of the invention.
  • a fifteenth aspect of the invention provides a pharmaceutical preparation containing a polyunsaturated fatty acid produced by a method according to a sixth aspect of the invention.
  • a sixteenth aspect of the invention provides prostaglandins synthesised by a biosynthetic pathway including a catalytic activity of a ⁇ 5-fatty acid desaturase according to a first or second aspect of the invention.
  • a seventeenth aspect of the invention provides a method for the modulation of prostaglandins synthesis by the control of the levels of expression of a DNA sequence according to a third aspect of the invention.
  • An eighteenth aspect of the invention provides a probe comprising all or part of a DNA sequence according to a third aspect of the invention,or an equivalent RNA sequence.
  • a nineteenth aspect of the invention provides a probe comprising all or part of a ⁇ 5-fatty acid desaturase polypeptide according to a fourth aspect of the invention.
  • a twentieth aspect of the invention provides a method of isolating ⁇ 5-fatty acid desaturases using a probe according to a nineteenth aspect of the invention.
  • gene of the invention may be transformed into human cells and
  • SEQ.l is a cDNA sequence encoding ⁇ 5-fatty acid desaturase from Mortierella alpina and;
  • SEQ.2 is a cDNA sequence encoding ⁇ 5-fatty acid desaturase from C. elegans.
  • SEQ.3 is the peptide sequence obtained by translating the gene sequence of SEQ.l.
  • SEQ.4 is the peptide sequence obtained by translating the gene sequence of SEQ2;
  • Fig.1 is a line-up of the gene encoding Mortierella alpina ⁇ 5-fatty acid desaturase with
  • Fig. 2 is a line-up of the gene encoding ⁇ 5-fatty acid desaturase with the C. elegans ⁇ 6
  • Fig. 3 is a gas chromatography trace of the fatty acid methyl esters of induced yeast cell
  • Fig. 4 is a gas chromatography trace of the fatty acid methyl esters of induced yeast cell
  • DNA sequences of the invention encode ⁇ 5-fatty acid desaturases and were cloned
  • DHL dihanogamma linolenic acid
  • AA arachidonic acid
  • ETA eicostatetraenoate
  • PCR Chain Reaction
  • DP degenerate oligonucleotide primers
  • amplification products were separated on 1 % agarose gels.
  • primers (P) based on the 660 bp product sequence.
  • Mortierella alpina cDNA library The fragment probe hybridised to 25 out of the 3.5 x 10 5 phage clones screened and one clone was shown, by restriction analysis, to have the
  • LI 1 This clone, designated LI 1, was selected for further analysis. Sequence analysis of LI 1 revealed an open reading frame of 1 ,338 bp in length encoding a
  • polypeptide of 446 amino acids When analyzed on the protein and genomic databases
  • LI 1 showed a low level 20% identity to the ⁇ 6 desaturase gene from Synechocystis sp.
  • sequence contains the variant QXXHH.
  • the translated sequence also contains a
  • cytochrome bs-like heme-binding domain at the N-terminus which includes the EHPGG
  • the 660 bp PCR product was gel purified and Southern blots of restricted Mortierella
  • cDNA was subcloned into the yeast expression vector, pYES2, supplied by Invitrogen TM
  • the estimated molecular weight of the product was 55-60
  • transgenic yeast were capable of desaturating Dihomo gamma linolenic acid at the ⁇ 5
  • MS80RFA operating at an ionization voltage of 70 eV with a scan range of 500-40 daltons
  • Mortierella alpina encodes a functional polypeptide involved in the synthesis of arachidonic acid in the presence of galactose and dihomo gamma linolenate.
  • cosmid T13F2 contained an open reading frame (ORF),
  • T13F2.1 which contained an N-terminal cytochrome b 5 domain (defined by the
  • microsomal desaturases contained a variant third histidine
  • glutamate substitution is present in both plant and animal ⁇ 6-fatty acid desaturases and in
  • PCR polymerase chain reaction
  • a DNA fragment of the correct predicted size was amplified (as visualised on a 1 %
  • Plasmid L4 was released from ⁇ clone L4 by excision and the cDNA
  • YCEDFor 5'-GCGAAGCTTAAAATGGTATTACGAGAGCAAGAGC-3' (annealing to the initiating methionine is indicated by the bold type face and the Hind HI
  • the amplified PCR product containing the complete coding region of L4 was ligated into
  • yeast expression vector pYES2 (Invitrogen), downstream of the GAEl promoter using
  • the translation product obtained from pYES2/L4 had a molecular weight of approximately
  • the fatty acid produced from di-homo- ⁇ -linolenic acid was further characterised by GCMS (Gas Chromatography Mass Spectrometry) and identified as arachidonic acid.
  • GCMS Gas Chromatography Mass Spectrometry

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

L'invention concerne des séquences d'ADNc codant des désaturases d'acide gras-Δ5, comprenant les séquences représentées dans SEQ.1 et SEQ.2.
PCT/GB1998/003895 1997-12-23 1998-12-23 Desaturase WO1999033958A2 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP2000526616A JP2002508932A (ja) 1997-12-23 1998-12-23 デサチュラーゼ
AU17748/99A AU1774899A (en) 1997-12-23 1998-12-23 Desaturase
KR1020007007019A KR20010033517A (ko) 1997-12-23 1998-12-23 불포화화효소
PL98344868A PL344868A1 (en) 1997-12-23 1998-12-23 Desaturase
CA002315297A CA2315297A1 (fr) 1997-12-23 1998-12-23 Desaturase
HU0101153A HUP0101153A3 (en) 1997-12-23 1998-12-23 Desaturase
BR9814434-0A BR9814434A (pt) 1997-12-23 1998-12-23 Desaturase
EP98962620A EP1042485A2 (fr) 1997-12-23 1998-12-23 Desaturase
EEP200000372A EE200000372A (et) 1997-12-23 1998-12-23 Desaturaas

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9727256.1A GB9727256D0 (en) 1997-12-23 1997-12-23 Desaturase gene
GBGB9814034.6A GB9814034D0 (en) 1998-06-29 1998-06-29 Desaturase gene
GB9727256.1 1998-06-29
GB9814034.6 1998-06-29

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US09582034 A-371-Of-International 2000-12-19
US10/340,779 Continuation US20030152983A1 (en) 1997-12-23 2003-01-13 Desaturase

Publications (2)

Publication Number Publication Date
WO1999033958A2 true WO1999033958A2 (fr) 1999-07-08
WO1999033958A3 WO1999033958A3 (fr) 1999-09-02

Family

ID=26312844

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1998/003895 WO1999033958A2 (fr) 1997-12-23 1998-12-23 Desaturase

Country Status (11)

Country Link
EP (1) EP1042485A2 (fr)
JP (1) JP2002508932A (fr)
KR (1) KR20010033517A (fr)
CN (1) CN1283230A (fr)
AU (1) AU1774899A (fr)
BR (1) BR9814434A (fr)
CA (1) CA2315297A1 (fr)
EE (1) EE200000372A (fr)
HU (1) HUP0101153A3 (fr)
PL (1) PL344868A1 (fr)
WO (1) WO1999033958A2 (fr)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001092489A3 (fr) * 2000-05-26 2002-05-10 Univ Washington Gene desaturase palmitate
WO2002026946A3 (fr) * 2000-09-28 2003-05-08 Bioriginal Food & Science Corp Fad4, fad5, fad5-2, and fad6, membres de la famille des desaturases d'acides gras et utilisations associees
EP1780275A1 (fr) * 2004-07-12 2007-05-02 Suntory Limited Polypeptide
WO2007042510A3 (fr) * 2005-10-13 2007-08-02 Basf Plant Science Gmbh Procede de production d'acide arachidonique et/ou d'acide eicosapentaenoique
US7601889B2 (en) 2001-03-26 2009-10-13 Napier Johnathan A Elongase gene and production of Δ9-polyunsaturated fatty acids
US7736884B2 (en) 2004-06-04 2010-06-15 Fluxome Sciences A/S Metabolically engineered Saccharomyces cells for the production of polyunsaturated fatty acids
US7807849B2 (en) 2004-04-22 2010-10-05 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US7834250B2 (en) 2004-04-22 2010-11-16 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US8816111B2 (en) 2012-06-15 2014-08-26 Commonwealth Scientific And Industrial Research Organisation Lipid comprising polyunsaturated fatty acids
US9695450B2 (en) 1998-12-07 2017-07-04 Washington State University Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
US9718759B2 (en) 2013-12-18 2017-08-01 Commonwealth Scientific And Industrial Research Organisation Lipid comprising docosapentaenoic acid
US9938486B2 (en) 2008-11-18 2018-04-10 Commonwealth Scientific And Industrial Research Organisation Enzymes and methods for producing omega-3 fatty acids
US10005713B2 (en) 2014-06-27 2018-06-26 Commonwealth Scientific And Industrial Research Organisation Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the sn-2 position
US10513717B2 (en) 2006-08-29 2019-12-24 Commonwealth Scientific And Industrial Research Organisation Synthesis of fatty acids

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0229578D0 (en) * 2002-12-19 2003-01-22 Univ Bristol Novel method for the production of polyunsaturated fatty acids
GB0403452D0 (en) * 2004-02-17 2004-03-24 Univ York Desaturase enzymes
CN101376020B (zh) * 2007-08-29 2013-05-01 益生生技开发股份有限公司 真菌免疫调节蛋白在抑制△5-去饱和酶中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972664A (en) * 1997-04-11 1999-10-26 Abbott Laboratories Methods and compositions for synthesis of long chain poly-unsaturated fatty acids

Cited By (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10351871B2 (en) 1998-12-07 2019-07-16 Washington State University Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
US9695450B2 (en) 1998-12-07 2017-07-04 Washington State University Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
WO2001092489A3 (fr) * 2000-05-26 2002-05-10 Univ Washington Gene desaturase palmitate
US7977469B2 (en) 2000-09-28 2011-07-12 Bioriginal Food & Science Corp. Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
WO2002026946A3 (fr) * 2000-09-28 2003-05-08 Bioriginal Food & Science Corp Fad4, fad5, fad5-2, and fad6, membres de la famille des desaturases d'acides gras et utilisations associees
US7087432B2 (en) 2000-09-28 2006-08-08 Bioriginal Food & Science Corp. Fad4, Fad5, Fad5-2 and Fad6, novel fatty acid desaturase family members and uses thereof
EP1911837A3 (fr) * 2000-09-28 2008-04-30 Bioriginal Food & Science Corp. FAD4, FAD5, FAD5-2, et FAD6, membres de la famille des désaturases d'acides gras, et leurs utilisations
US7671252B2 (en) 2000-09-28 2010-03-02 Bioriginal Food & Science Corp. Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof
US9359597B2 (en) 2000-09-28 2016-06-07 Bioriginal Food & Science Corp. Fad4, Fad5, Fad5-2, and Fad6, novel fatty acid desaturase family members and uses thereof
US8088906B2 (en) 2000-09-28 2012-01-03 Bioriginal Food & Science Corp. FAD4, FAD5, FAD5-2, and FAD6, novel fatty acid desaturase family members and uses thereof
US7601889B2 (en) 2001-03-26 2009-10-13 Napier Johnathan A Elongase gene and production of Δ9-polyunsaturated fatty acids
US9458410B2 (en) 2004-04-22 2016-10-04 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cell
US8158392B1 (en) 2004-04-22 2012-04-17 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US7932438B2 (en) 2004-04-22 2011-04-26 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US7834250B2 (en) 2004-04-22 2010-11-16 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US9970033B2 (en) 2004-04-22 2018-05-15 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cell
US8071341B2 (en) 2004-04-22 2011-12-06 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US7807849B2 (en) 2004-04-22 2010-10-05 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US11220698B2 (en) 2004-04-22 2022-01-11 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US9963723B2 (en) 2004-04-22 2018-05-08 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US9951357B2 (en) 2004-04-22 2018-04-24 Commonweatlh Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cell
US9926579B2 (en) 2004-04-22 2018-03-27 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cell
US10443079B2 (en) 2004-04-22 2019-10-15 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cell
US11597953B2 (en) 2004-04-22 2023-03-07 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US9994880B2 (en) 2004-04-22 2018-06-12 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cell
US9453183B2 (en) 2004-04-22 2016-09-27 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cell
US10781463B2 (en) 2004-04-22 2020-09-22 Commonwealth Scientific And Industrial Research Organisation Synthesis of long-chain polyunsaturated fatty acids by recombinant cells
US7736884B2 (en) 2004-06-04 2010-06-15 Fluxome Sciences A/S Metabolically engineered Saccharomyces cells for the production of polyunsaturated fatty acids
EP1780275A4 (fr) * 2004-07-12 2008-05-28 Suntory Ltd Polypeptide
US7928294B2 (en) 2004-07-12 2011-04-19 Suntory Holdings Limited Polypeptide having Δ5 desaturating activity, polynucleotide coding for the polypeptide, and use thereof
EP1780275A1 (fr) * 2004-07-12 2007-05-02 Suntory Limited Polypeptide
WO2007042510A3 (fr) * 2005-10-13 2007-08-02 Basf Plant Science Gmbh Procede de production d'acide arachidonique et/ou d'acide eicosapentaenoique
US8273958B2 (en) 2005-10-13 2012-09-25 Basf Plant Science Gmbh Process for the production of arachidonic acid and/or eicosapentaenoic acid
US8258371B2 (en) 2005-10-13 2012-09-04 Basf Plant Science Gmbh Process for the production of arachidonic acid and/or eicosapentaenoic acid
EP2450434A3 (fr) * 2005-10-13 2012-08-08 BASF Plant Science GmbH Processus de production d'acide arachidonique et/ou d'acide eicosapentaénoique
US8017839B2 (en) 2005-10-13 2011-09-13 Basf Plant Science Gmbh Process for the production of arachidonic acid and/or eicosapentaenoic acid
US10513717B2 (en) 2006-08-29 2019-12-24 Commonwealth Scientific And Industrial Research Organisation Synthesis of fatty acids
US9938486B2 (en) 2008-11-18 2018-04-10 Commonwealth Scientific And Industrial Research Organisation Enzymes and methods for producing omega-3 fatty acids
US8816111B2 (en) 2012-06-15 2014-08-26 Commonwealth Scientific And Industrial Research Organisation Lipid comprising polyunsaturated fatty acids
US9556102B2 (en) 2012-06-15 2017-01-31 Commonwealth Scientific And Industrial Research Organisation Process for producing ethyl esters of polyunsaturated fatty acids
US8946460B2 (en) 2012-06-15 2015-02-03 Commonwealth Scientific And Industrial Research Organisation Process for producing polyunsaturated fatty acids in an esterified form
US9550718B2 (en) 2012-06-15 2017-01-24 Commonwealth Scientific And Industrial Research Organisation Lipid comprising polyunsaturated fatty acids
US10335386B2 (en) 2012-06-15 2019-07-02 Commonwealth Scientific And Industrial Research Organisation Lipid comprising polyunsaturated fatty acids
US9932289B2 (en) 2012-06-15 2018-04-03 Commonwealth Scientific And Industrial Research Ogranisation Process for producing ethyl esters of polyunsaturated fatty acids
US9718759B2 (en) 2013-12-18 2017-08-01 Commonwealth Scientific And Industrial Research Organisation Lipid comprising docosapentaenoic acid
US9725399B2 (en) 2013-12-18 2017-08-08 Commonwealth Scientific And Industrial Research Organisation Lipid comprising long chain polyunsaturated fatty acids
US10800729B2 (en) 2013-12-18 2020-10-13 Commonwealth Scientific And Industrial Research Organisation Lipid comprising long chain polyunsaturated fatty acids
US10190073B2 (en) 2013-12-18 2019-01-29 Commonwealth Scientific And Industrial Research Organisation Lipid comprising long chain polyunsaturated fatty acids
US10125084B2 (en) 2013-12-18 2018-11-13 Commonwealth Scientific And Industrial Research Organisation Lipid comprising docosapentaenoic acid
US11623911B2 (en) 2013-12-18 2023-04-11 Commonwealth Scientific And Industrial Research Organisation Lipid comprising docosapentaenoic acid
US10005713B2 (en) 2014-06-27 2018-06-26 Commonwealth Scientific And Industrial Research Organisation Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the sn-2 position
US10793507B2 (en) 2014-06-27 2020-10-06 Commonwealth Scientific And Industrial Research Organisation Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the SN-2 position

Also Published As

Publication number Publication date
WO1999033958A3 (fr) 1999-09-02
BR9814434A (pt) 2001-10-23
KR20010033517A (ko) 2001-04-25
AU1774899A (en) 1999-07-19
PL344868A1 (en) 2001-11-19
HUP0101153A2 (hu) 2001-08-28
EP1042485A2 (fr) 2000-10-11
CA2315297A1 (fr) 1999-07-08
CN1283230A (zh) 2001-02-07
EE200000372A (et) 2001-12-17
HUP0101153A3 (en) 2006-03-28
JP2002508932A (ja) 2002-03-26

Similar Documents

Publication Publication Date Title
Michaelson et al. Functional identification of a fatty acid Δ5 desaturase gene from Caenorhabditis elegans
EP1042485A2 (fr) Desaturase
EP1911837B1 (fr) FAD5-2, membre de la famille des désaturases d'acides gras, et ses utilisations
Wallis et al. The Δ8-Desaturase ofEuglena gracilis: An Alternate Pathway for Synthesis of 20-Carbon Polyunsaturated Fatty Acids
Michaelson et al. Isolation of a Δ5-Fatty Acid Desaturase Gene fromMortierella alpina
CN101617040B (zh) △17去饱和酶及其在制备多不饱和脂肪酸中的用途
EP1656449B1 (fr) Desaturases des acides gras issues de primula
JP5762291B2 (ja) 変異δ５デサチュラーゼと、多価不飽和脂肪酸の製造におけるそれらの使用
CA2656786C (fr) Desaturases d'acides gras et leurs utilisations
Zhang et al. Identification and characterization of a novel Δ6-fatty acid desaturase gene from Rhizopus arrhizus
US20020045232A1 (en) Production of conjugated linoleic and linolenic acids in plants
CA2717348A1 (fr) Desaturase .delta.4 et son utilisation dans la fabrication d'acides gras polyinsatures
AU2011235307A1 (en) Pentose phosphate pathway upregulation to increase production of non-native products of interest in transgenic microorganisms
Passorn et al. Heterologous expression of Mucor rouxii Δ12-desaturase gene in Saccharomyces cerevisiae
Kim et al. Functional characterization of a delta 6-desaturase gene from the black seabream (Acanthopagrus schlegeli)
US20030152983A1 (en) Desaturase
WO1998038314A1 (fr) Gene de δ9-desaturase
EP1790720B1 (fr) Polypeptide ayant un effet consistant a rendre insature un acide gras omega3, polynucleotide codant pour le polypeptide et utilisation de ceux-ci
NO326619B1 (no) Fremgangsmate ved fremstilling av acetyleniske forbindelser ved anvendelse av delta-12-acetylenase, DNA-sekvenser som koder for delta-12-acetylenasen samt organismer transformert med slike DNA-sekvenser.
KR20070101862A (ko) 효모 내에서 도코사헥사에노산(ｄｈａ)의 재조합 생산
Na-Ranong et al. Targeted mutagenesis of a fatty acid Δ6-desaturase from Mucor rouxii: role of amino acid residues adjacent to histidine-rich motif II
Kim et al. Functional characterization of polyunsaturated fatty acid delta 6-desaturase and elongase genes from the black seabream (Acanthopagrus schlegelii)
RU2266330C2 (ru) БИОЛОГИЧЕСКИ АКТИВНАЯ ЖИВОТНАЯ Δ5 - ДЕСАТУРАЗА ЖИРНЫХ КИСЛОТ, КОДИРУЮЩАЯ ЕЁ ПОСЛЕДОВАТЕЛЬНОСТЬ ДНК, КЛОНИРУЮЩИЙ И ЭКСПРЕССИРУЮЩИЙ ВЕКТОРЫ, СОДЕРЖАЩИЕ УКАЗАННУЮ ПОСЛЕДОВАТЕЛЬНОСТЬ, СПОСОБ ПОЛУЧЕНИЯ ПОЛИНЕНАСЫЩЕННЫХ ЖИРНЫХ КИСЛОТ, СПОСОБ ПРЕВРАЩЕНИЯ ДИГОМО-γ-ЛИНОЛЕНОВОЙ КИСЛОТЫ В АРАХИДОНОВУЮ КИСЛОТУ, ЗОНД (ВАРИАНТЫ) И СПОСОБ ВЫЯВЛЕНИЯ Δ5 - ДЕСАТУРАЗЫ С ЕГО ИСПОЛЬЗОВАНИЕМ
Jeennor et al. The codon-optimized Δ 6-desaturase gene of Pythium sp. as an empowering tool for engineering n 3/n 6 polyunsaturated fatty acid biosynthesis
Yu et al. Submesoscale characteristics and transcription of a fatty acid elongase gene from a freshwater green microalgae, Myrmecia incisa Reisigl

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 98812505.6

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2315297

Country of ref document: CA

Ref document number: 2315297

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/2000/006158

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 1020007007019

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 1998962620

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 17748/99

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: IN/PCT/2000/157/KOL

Country of ref document: IN

WWP Wipo information: published in national office

Ref document number: 1998962620

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 09582034

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1020007007019

Country of ref document: KR

WWR Wipo information: refused in national office

Ref document number: 1020007007019

Country of ref document: KR

WWW Wipo information: withdrawn in national office

Ref document number: 1998962620

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载